Dengue fever is a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely to affect individual’s tropical and subtropical countries. Increasing prevalence of dengue is expected to propel growth of the global dengue vaccine market over the forecast period.
- This report provides in-depth analysis of the global Dengue Vaccine and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global Dengue Vaccine based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global Dengue Vaccine report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
- Hospitals
- Government Institutes
- NGOs
- Latin America
- By End User
- Hospitals
- Government Institutes
- NGOs
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Asia Pacific
- By End User
- Hospitals
- Government Institutes
- NGOs
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By End User
- Hospitals
- Government Institutes
- NGOs
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By End User
- Hospitals
- Government Institutes
- NGOs
- By Country:
- South Africa
- Central Africa
- North Africa
- Rest of World
- By End User
- Hospitals
- Government Institutes
- NGOs
- Sanofi *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline
- Merck & Co.
“*” marked represents similar segmentation in other categories in the respective section.
